预防性保留乳头乳房切除术联合即刻乳房重建:法国前瞻性试验结果
该前瞻性多中心试验评估预防性保留乳头乳房切除术(NSM)联合即刻乳房重建(IBR)的乳头乳晕复合体(NAC)坏死率。59例女性中,术后并发症粗发生率为25%,完全NAC坏死2例(3%),部分或全部坏死9例(15%),无需NAC切除。发生NAC坏死的患者中位BMI显著低于未发生者。
要点
- 预防性NSM联合IBR的完全NAC坏死率低(3%),无需NAC切除。
- 术后并发症粗发生率为25%,部分或全部NAC坏死率为15%。
- 发生NAC坏死的患者中位BMI更低(20.0 vs 21.3 kg/m²)。
核心结论
- 预防性NSM联合IBR与较低的完全NAC坏死风险相关。
研究设计与样本
- 法国前瞻性多中心MAPAM试验的补充试验,纳入59例行预防性NSM的女性,记录患者特征和手术数据,分析术后并发症尤其是NAC坏死。
主要发现
- 59例女性中19例(32%)的切口部分位于NAC上。
- 重建使用46个永久假体和13个扩张器。
- 术后并发症粗发生率为25%(15例患者)。
- 完全NAC坏死2例(3%),部分或全部坏死9例(15%),无需NAC切除。
- 发生全部或部分NAC坏死的女性中位BMI低于未发生者(20.0 vs 21.3 kg/m²;P=0.034)。
临床怎么用
- 预防性NSM联合IBR时,完全NAC坏死风险较低,无需常规NAC切除。
- 低BMI患者发生NAC坏死的风险可能更高,需加强术后监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) is used increasingly when performing a prophylactic mastectomy. Few prospective studies have reported on complication rates. This complementary trial to the French prospective multicentre MAPAM trial aimed to evaluate the nipple-areola complex (NAC) necrosis rate in prophylactic NSM with IBR. METHODS: Patient characteristics and surgical data were recorded. Morbidity after prophylactic NSM with a focus on NAC necrosis was analysed. RESULTS: Among 59 women undergoing prophylactic NSM, 19 (32 per cent) of the incisions were partly on the NAC. Reconstructions were performed with 46 definitive implants and 13 expanders. The crude rate of postoperative complications was 25 per cent (15 patients). Complete NAC necrosis was reported in two women (3 per cent) and partial or total necrosis in nine (15 per cent). No NAC resection was necessary. Median BMI was lower in women with total or partial NAC necrosis compared with the others (20.0 versus 21.3 kg/m2 respectively; P = 0.034). CONCLUSION: Results of this prospective study confirm that prophylactic NSM with IBR is associated with a low risk of total NAC necrosis.
引用
- Houvenaeghel G, Cohen M, Dammacco MA, et al. Prophylactic nipple-sparing mastectomy with immediate breast reconstruction: results of a French prospective trial. Br J Surg. 2021. PMID: 33793719. doi:10.1093/bjs/znaa082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。